Quantinno Capital Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Quantinno Capital Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$228K	Buy	+2,193	New	+$232K	﹤0.01%	3160

Other funds holding PJP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Quantinno Capital Management's PJP Position: Q1 2026 in Review

Quantinno Capital Management opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q1 2026: 2,193 shares worth $228K. The stake represents ﹤0.01% of the portfolio and ranks #3160 among its holdings.

119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

Quantinno Capital Management held 2,193 shares of Invesco Pharmaceuticals ETF worth $228K as of Q1 2026.
Invesco Pharmaceuticals ETF was a new Quantinno Capital Management position in Q1 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #3160 holding.
119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.